Multi-purpose silastic dual-lumen central venous catheters for both collection and transplantation of hematopoietic progenitor cells
Open Access
- 27 March 2000
- journal article
- technical report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 25 (7) , 779-785
- https://doi.org/10.1038/sj.bmt.1702225
Abstract
Autologous peripheral blood progenitor cell (PBPC) transplantation frequently requires sequential placement and use of two separate central venous catheters: (1) a short-term, large-bore, stiff device inserted for leukapheresis, and after removal of that device, (2) a long-term, multi-lumen, flexible, Silastic catheter for administration of high-dose chemotherapy, re-infusion of hematopoietic cells, and intensive supportive care. We reviewed our recent experience with two dual-lumen, large-bore, Silastic multi-purpose (‘hybrid’) catheters, each of which can be used as a single device for both leukapheresis and long-term supportive care throughout the transplant process. Quinton-Raaf PermCath and Bard-Hickman hemodialysis/apheresis dual-lumen catheters were used as the sole venous access device in 112 consecutive patients who underwent autologous PBPC collection and transplantation. The catheter exit site was monitored three times a week, and lumen patency was assessed using clinical and radiologic techniques. Catheters were removed prematurely for persistent thrombus, positive blood cultures despite appropriate antibiotics, or mechanical dysfunction. There were no intra-operative or immediate post-operative complications relating to insertion. Thirty-two patients experienced catheter occlusion necessitating urokinase instillation. Persistent occlusive problems were noted in 16 patients, and in 10 patients the catheter had to be removed. Two exit site infections and 17 bacteremias occurred. Catheters had to be removed for persistent infection in two subjects and for mechanical problems in five others. Cost analysis comparing the hybrid catheters alone vs conventional devices revealed a charge of $4230 in patients with hybrid catheters vs $7530 in those requiring a temporary non-Silastic dialysis catheter in addition to a flexible, long-term Silastic catheter. Hybrid, Silastic, dual-lumen, large-bore central venous catheters are safe, cost-effective and convenient multi-purpose venous access devices that may be used in the setting of autologous PBPC collection and transplantation. The rate of thrombotic, infectious and mechanical complications appears comparable to other central venous access devices. Bone Marrow Transplantation (2000) 25, 779–785.Keywords
This publication has 34 references indexed in Scilit:
- Non-tunneled catheters for the collection and transplantation of peripheral blood stem cells in childrenBone Marrow Transplantation, 1997
- A prospective analysis of 949 long-term central venous access catheters for ambulatory chemotherapy in patients with gastrointestinal malignancyEuropean Journal Of Cancer, 1997
- Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantationTransfusion, 1996
- Complications of Peripheral Blood Stem Cell Harvesting: Review of 554 PBSC LeukapheresesJournal of Hematotherapy, 1995
- Large‐bore central venous catheters for the collection of peripheral blood stem cellsJournal of Clinical Apheresis, 1995
- Central Venous Catheter Clots: Incidence, Clinical Significance and Catheter Care in Patients with Hematologic MalignanciesPediatric Hematology and Oncology, 1995
- Large Volume Leukapheresis to Maximize Peripheral Blood Stem Cell CollectionJournal of Hematotherapy, 1993
- Central venous catheters for apheresis accessJournal of Clinical Apheresis, 1992
- Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSFEuropean Journal of Cancer and Clinical Oncology, 1990
- Thrombotic complications of subclavian apheresis catheters in cancer patients: Prevention with heparin infusionJournal of Clinical Apheresis, 1990